The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
Abstract Background Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients. Methods The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel...
Gespeichert in:
| Veröffentlicht in: | Inflammatory bowel diseases 2022-11, Vol.28 (11), p.1687-1695 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1695 |
|---|---|
| container_issue | 11 |
| container_start_page | 1687 |
| container_title | Inflammatory bowel diseases |
| container_volume | 28 |
| creator | Kaplan, Gilaad G Underwood, Fox E Coward, Stephanie Agrawal, Manasi Ungaro, Ryan C Brenner, Erica J Gearry, Richard B Kissous-Hunt, Michele Lewis, James D Ng, Siew C Rahier, Jean-Francois Reinisch, Walter Steinwurz, Flavio Zhang, Xian Kappelman, Michael D Colombel, Jean-Frederic |
| description | Abstract
Background
Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients.
Methods
The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is an international registry of IBD patients diagnosed with COVID-19. The average percent changes (APCs) were calculated in weekly reported cases of COVID-19 during the periods of March 22 to September 12, September 13 to December 12, 2020, and December 13 to July 31, 2021.
Results
Across 73 countries, 6404 cases of COVID-19 were reported in IBD patients. COVID-19 reporting decreased globally by 4.2% per week (95% CI, −5.3% to −3.0%) from March 22 to September 12, 2020, then climbed by 10.2% per week (95% CI, 8.1%-12.3%) from September 13 to December 12, 2020, and then declined by 6.3% per week (95% CI, −7.8% to −4.7%). In the fall of 2020, weekly reporting climbed in North America (APC, 11.3%; 95% CI, 8.8-13.8) and Europe (APC, 17.7%; 95% CI, 12.1%-23.5%), whereas reporting was stable in Asia (APC, −8.1%; 95% CI, −15.6-0.1). From December 13, 2020, to July 31, 2021, reporting of COVID-19 in those with IBD declined in North America (APC, −8.5%; 95% CI, −10.2 to −6.7) and Europe (APC, −5.4%; 95% CI, −7.2 to −3.6) and was stable in Latin America (APC, −1.5%; 95% CI, −3.5% to 0.6%).
Conclusions
Temporal trends in reporting of COVID-19 in those with IBD are consistent with the epidemiological patterns COVID-19 globally. |
| doi_str_mv | 10.1093/ibd/izab339 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8807298</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ibd/izab339</oup_id><sourcerecordid>2620087951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-7ba2e09a2e0a0bf203b1288fde80442dd1bb1eaf629488841e6260b19a3a88533</originalsourceid><addsrcrecordid>eNp9kctrGzEQxkVJaR7tqfegUyiEbfRY70o9BFynD0OKe3Cboxh5Z2MV7Wqz2nVw__rI2A3tpQzMDMyPbz74CHnL2XvOtLxytrpyv8FKqV-QEz6RRZarPD9KOytVxrRWx-Q0xl-MiVT6FTmWEyYFL8oTgss10m-jH1znkd7BBiMNNZ0tfs5vMq6pa-l3GBy2Q6R3bljTeVt7aBoYQr-lH8MjenrjIkLED3RKl9h0oQdPlz22FZ224LfRxdfkZQ0-4pvDPCM_Pn9azr5mt4sv89n0NlvlXAxZaUEg07sGzNaCScuFUnWFiuW5qCpuLUeoC6FzpVTOsRAFs1yDBKUmUp6R671uN9oGq1WyncyYrncN9FsTwJl_L61bm_uwMUqxUmiVBN4dBPrwMGIcTOPiCr2HFsMYjSgEY6rUE57Qyz266kOMPdbPbzgzu2BMCsYcgkn0-d_Ontk_SSTgYg-Esfuv0hPQ1pdP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620087951</pqid></control><display><type>article</type><title>The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis</title><source>MEDLINE</source><source>Oxford University Press Journals Current</source><creator>Kaplan, Gilaad G ; Underwood, Fox E ; Coward, Stephanie ; Agrawal, Manasi ; Ungaro, Ryan C ; Brenner, Erica J ; Gearry, Richard B ; Kissous-Hunt, Michele ; Lewis, James D ; Ng, Siew C ; Rahier, Jean-Francois ; Reinisch, Walter ; Steinwurz, Flavio ; Zhang, Xian ; Kappelman, Michael D ; Colombel, Jean-Frederic</creator><creatorcontrib>Kaplan, Gilaad G ; Underwood, Fox E ; Coward, Stephanie ; Agrawal, Manasi ; Ungaro, Ryan C ; Brenner, Erica J ; Gearry, Richard B ; Kissous-Hunt, Michele ; Lewis, James D ; Ng, Siew C ; Rahier, Jean-Francois ; Reinisch, Walter ; Steinwurz, Flavio ; Zhang, Xian ; Kappelman, Michael D ; Colombel, Jean-Frederic</creatorcontrib><description>Abstract
Background
Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients.
Methods
The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is an international registry of IBD patients diagnosed with COVID-19. The average percent changes (APCs) were calculated in weekly reported cases of COVID-19 during the periods of March 22 to September 12, September 13 to December 12, 2020, and December 13 to July 31, 2021.
Results
Across 73 countries, 6404 cases of COVID-19 were reported in IBD patients. COVID-19 reporting decreased globally by 4.2% per week (95% CI, −5.3% to −3.0%) from March 22 to September 12, 2020, then climbed by 10.2% per week (95% CI, 8.1%-12.3%) from September 13 to December 12, 2020, and then declined by 6.3% per week (95% CI, −7.8% to −4.7%). In the fall of 2020, weekly reporting climbed in North America (APC, 11.3%; 95% CI, 8.8-13.8) and Europe (APC, 17.7%; 95% CI, 12.1%-23.5%), whereas reporting was stable in Asia (APC, −8.1%; 95% CI, −15.6-0.1). From December 13, 2020, to July 31, 2021, reporting of COVID-19 in those with IBD declined in North America (APC, −8.5%; 95% CI, −10.2 to −6.7) and Europe (APC, −5.4%; 95% CI, −7.2 to −3.6) and was stable in Latin America (APC, −1.5%; 95% CI, −3.5% to 0.6%).
Conclusions
Temporal trends in reporting of COVID-19 in those with IBD are consistent with the epidemiological patterns COVID-19 globally.</description><identifier>ISSN: 1078-0998</identifier><identifier>EISSN: 1536-4844</identifier><identifier>DOI: 10.1093/ibd/izab339</identifier><identifier>PMID: 35032167</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Chronic Disease ; COVID-19 ; Europe - epidemiology ; Humans ; Incidence ; Inflammatory Bowel Diseases - epidemiology ; Original s - Clinical</subject><ispartof>Inflammatory bowel diseases, 2022-11, Vol.28 (11), p.1687-1695</ispartof><rights>2022 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. 2022</rights><rights>2022 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-7ba2e09a2e0a0bf203b1288fde80442dd1bb1eaf629488841e6260b19a3a88533</citedby><cites>FETCH-LOGICAL-c412t-7ba2e09a2e0a0bf203b1288fde80442dd1bb1eaf629488841e6260b19a3a88533</cites><orcidid>0000-0003-0675-7226 ; 0000-0003-2719-0556 ; 0000-0003-4729-1485 ; 0000-0001-8687-3758 ; 0000-0001-6472-249X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35032167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaplan, Gilaad G</creatorcontrib><creatorcontrib>Underwood, Fox E</creatorcontrib><creatorcontrib>Coward, Stephanie</creatorcontrib><creatorcontrib>Agrawal, Manasi</creatorcontrib><creatorcontrib>Ungaro, Ryan C</creatorcontrib><creatorcontrib>Brenner, Erica J</creatorcontrib><creatorcontrib>Gearry, Richard B</creatorcontrib><creatorcontrib>Kissous-Hunt, Michele</creatorcontrib><creatorcontrib>Lewis, James D</creatorcontrib><creatorcontrib>Ng, Siew C</creatorcontrib><creatorcontrib>Rahier, Jean-Francois</creatorcontrib><creatorcontrib>Reinisch, Walter</creatorcontrib><creatorcontrib>Steinwurz, Flavio</creatorcontrib><creatorcontrib>Zhang, Xian</creatorcontrib><creatorcontrib>Kappelman, Michael D</creatorcontrib><creatorcontrib>Colombel, Jean-Frederic</creatorcontrib><title>The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis</title><title>Inflammatory bowel diseases</title><addtitle>Inflamm Bowel Dis</addtitle><description>Abstract
Background
Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients.
Methods
The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is an international registry of IBD patients diagnosed with COVID-19. The average percent changes (APCs) were calculated in weekly reported cases of COVID-19 during the periods of March 22 to September 12, September 13 to December 12, 2020, and December 13 to July 31, 2021.
Results
Across 73 countries, 6404 cases of COVID-19 were reported in IBD patients. COVID-19 reporting decreased globally by 4.2% per week (95% CI, −5.3% to −3.0%) from March 22 to September 12, 2020, then climbed by 10.2% per week (95% CI, 8.1%-12.3%) from September 13 to December 12, 2020, and then declined by 6.3% per week (95% CI, −7.8% to −4.7%). In the fall of 2020, weekly reporting climbed in North America (APC, 11.3%; 95% CI, 8.8-13.8) and Europe (APC, 17.7%; 95% CI, 12.1%-23.5%), whereas reporting was stable in Asia (APC, −8.1%; 95% CI, −15.6-0.1). From December 13, 2020, to July 31, 2021, reporting of COVID-19 in those with IBD declined in North America (APC, −8.5%; 95% CI, −10.2 to −6.7) and Europe (APC, −5.4%; 95% CI, −7.2 to −3.6) and was stable in Latin America (APC, −1.5%; 95% CI, −3.5% to 0.6%).
Conclusions
Temporal trends in reporting of COVID-19 in those with IBD are consistent with the epidemiological patterns COVID-19 globally.</description><subject>Chronic Disease</subject><subject>COVID-19</subject><subject>Europe - epidemiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Inflammatory Bowel Diseases - epidemiology</subject><subject>Original s - Clinical</subject><issn>1078-0998</issn><issn>1536-4844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kctrGzEQxkVJaR7tqfegUyiEbfRY70o9BFynD0OKe3Cboxh5Z2MV7Wqz2nVw__rI2A3tpQzMDMyPbz74CHnL2XvOtLxytrpyv8FKqV-QEz6RRZarPD9KOytVxrRWx-Q0xl-MiVT6FTmWEyYFL8oTgss10m-jH1znkd7BBiMNNZ0tfs5vMq6pa-l3GBy2Q6R3bljTeVt7aBoYQr-lH8MjenrjIkLED3RKl9h0oQdPlz22FZ224LfRxdfkZQ0-4pvDPCM_Pn9azr5mt4sv89n0NlvlXAxZaUEg07sGzNaCScuFUnWFiuW5qCpuLUeoC6FzpVTOsRAFs1yDBKUmUp6R671uN9oGq1WyncyYrncN9FsTwJl_L61bm_uwMUqxUmiVBN4dBPrwMGIcTOPiCr2HFsMYjSgEY6rUE57Qyz266kOMPdbPbzgzu2BMCsYcgkn0-d_Ontk_SSTgYg-Esfuv0hPQ1pdP</recordid><startdate>20221102</startdate><enddate>20221102</enddate><creator>Kaplan, Gilaad G</creator><creator>Underwood, Fox E</creator><creator>Coward, Stephanie</creator><creator>Agrawal, Manasi</creator><creator>Ungaro, Ryan C</creator><creator>Brenner, Erica J</creator><creator>Gearry, Richard B</creator><creator>Kissous-Hunt, Michele</creator><creator>Lewis, James D</creator><creator>Ng, Siew C</creator><creator>Rahier, Jean-Francois</creator><creator>Reinisch, Walter</creator><creator>Steinwurz, Flavio</creator><creator>Zhang, Xian</creator><creator>Kappelman, Michael D</creator><creator>Colombel, Jean-Frederic</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0675-7226</orcidid><orcidid>https://orcid.org/0000-0003-2719-0556</orcidid><orcidid>https://orcid.org/0000-0003-4729-1485</orcidid><orcidid>https://orcid.org/0000-0001-8687-3758</orcidid><orcidid>https://orcid.org/0000-0001-6472-249X</orcidid></search><sort><creationdate>20221102</creationdate><title>The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis</title><author>Kaplan, Gilaad G ; Underwood, Fox E ; Coward, Stephanie ; Agrawal, Manasi ; Ungaro, Ryan C ; Brenner, Erica J ; Gearry, Richard B ; Kissous-Hunt, Michele ; Lewis, James D ; Ng, Siew C ; Rahier, Jean-Francois ; Reinisch, Walter ; Steinwurz, Flavio ; Zhang, Xian ; Kappelman, Michael D ; Colombel, Jean-Frederic</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-7ba2e09a2e0a0bf203b1288fde80442dd1bb1eaf629488841e6260b19a3a88533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Chronic Disease</topic><topic>COVID-19</topic><topic>Europe - epidemiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Inflammatory Bowel Diseases - epidemiology</topic><topic>Original s - Clinical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaplan, Gilaad G</creatorcontrib><creatorcontrib>Underwood, Fox E</creatorcontrib><creatorcontrib>Coward, Stephanie</creatorcontrib><creatorcontrib>Agrawal, Manasi</creatorcontrib><creatorcontrib>Ungaro, Ryan C</creatorcontrib><creatorcontrib>Brenner, Erica J</creatorcontrib><creatorcontrib>Gearry, Richard B</creatorcontrib><creatorcontrib>Kissous-Hunt, Michele</creatorcontrib><creatorcontrib>Lewis, James D</creatorcontrib><creatorcontrib>Ng, Siew C</creatorcontrib><creatorcontrib>Rahier, Jean-Francois</creatorcontrib><creatorcontrib>Reinisch, Walter</creatorcontrib><creatorcontrib>Steinwurz, Flavio</creatorcontrib><creatorcontrib>Zhang, Xian</creatorcontrib><creatorcontrib>Kappelman, Michael D</creatorcontrib><creatorcontrib>Colombel, Jean-Frederic</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inflammatory bowel diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaplan, Gilaad G</au><au>Underwood, Fox E</au><au>Coward, Stephanie</au><au>Agrawal, Manasi</au><au>Ungaro, Ryan C</au><au>Brenner, Erica J</au><au>Gearry, Richard B</au><au>Kissous-Hunt, Michele</au><au>Lewis, James D</au><au>Ng, Siew C</au><au>Rahier, Jean-Francois</au><au>Reinisch, Walter</au><au>Steinwurz, Flavio</au><au>Zhang, Xian</au><au>Kappelman, Michael D</au><au>Colombel, Jean-Frederic</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis</atitle><jtitle>Inflammatory bowel diseases</jtitle><addtitle>Inflamm Bowel Dis</addtitle><date>2022-11-02</date><risdate>2022</risdate><volume>28</volume><issue>11</issue><spage>1687</spage><epage>1695</epage><pages>1687-1695</pages><issn>1078-0998</issn><eissn>1536-4844</eissn><abstract>Abstract
Background
Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients.
Methods
The Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) is an international registry of IBD patients diagnosed with COVID-19. The average percent changes (APCs) were calculated in weekly reported cases of COVID-19 during the periods of March 22 to September 12, September 13 to December 12, 2020, and December 13 to July 31, 2021.
Results
Across 73 countries, 6404 cases of COVID-19 were reported in IBD patients. COVID-19 reporting decreased globally by 4.2% per week (95% CI, −5.3% to −3.0%) from March 22 to September 12, 2020, then climbed by 10.2% per week (95% CI, 8.1%-12.3%) from September 13 to December 12, 2020, and then declined by 6.3% per week (95% CI, −7.8% to −4.7%). In the fall of 2020, weekly reporting climbed in North America (APC, 11.3%; 95% CI, 8.8-13.8) and Europe (APC, 17.7%; 95% CI, 12.1%-23.5%), whereas reporting was stable in Asia (APC, −8.1%; 95% CI, −15.6-0.1). From December 13, 2020, to July 31, 2021, reporting of COVID-19 in those with IBD declined in North America (APC, −8.5%; 95% CI, −10.2 to −6.7) and Europe (APC, −5.4%; 95% CI, −7.2 to −3.6) and was stable in Latin America (APC, −1.5%; 95% CI, −3.5% to 0.6%).
Conclusions
Temporal trends in reporting of COVID-19 in those with IBD are consistent with the epidemiological patterns COVID-19 globally.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>35032167</pmid><doi>10.1093/ibd/izab339</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0675-7226</orcidid><orcidid>https://orcid.org/0000-0003-2719-0556</orcidid><orcidid>https://orcid.org/0000-0003-4729-1485</orcidid><orcidid>https://orcid.org/0000-0001-8687-3758</orcidid><orcidid>https://orcid.org/0000-0001-6472-249X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1078-0998 |
| ispartof | Inflammatory bowel diseases, 2022-11, Vol.28 (11), p.1687-1695 |
| issn | 1078-0998 1536-4844 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8807298 |
| source | MEDLINE; Oxford University Press Journals Current |
| subjects | Chronic Disease COVID-19 Europe - epidemiology Humans Incidence Inflammatory Bowel Diseases - epidemiology Original s - Clinical |
| title | The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A26%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Multiple%20Waves%20of%20COVID-19%20in%20Patients%20With%20Inflammatory%20Bowel%20Disease:%20A%20Temporal%20Trend%20Analysis&rft.jtitle=Inflammatory%20bowel%20diseases&rft.au=Kaplan,%20Gilaad%20G&rft.date=2022-11-02&rft.volume=28&rft.issue=11&rft.spage=1687&rft.epage=1695&rft.pages=1687-1695&rft.issn=1078-0998&rft.eissn=1536-4844&rft_id=info:doi/10.1093/ibd/izab339&rft_dat=%3Cproquest_pubme%3E2620087951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2620087951&rft_id=info:pmid/35032167&rft_oup_id=10.1093/ibd/izab339&rfr_iscdi=true |